Skip to content

Cerus CERS Investing Cash Flow

Investing Cash Flow at other companies

CorMedix logo
CorMedixCRMD
$2.97M+1,621%
Haemonetics logo
HaemoneticsHAE
-$86.61M
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
-$93.2M-3,314%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
$90.89M+196%
QuidelOrtho Corporation logo
QuidelOrtho CorporationQDEL
-$34M+39.5%
ADMA Biologics logo
ADMA BiologicsADMA
$2.4M+151%

Other financials

Income statement

See full
Revenue$53.7M+24.1%
Operating income-$354.0K+94.0%
Net income-$1.6M+78.7%
EPS (diluted)-$0.01+75.0%

Balance sheet

See full
Cash & equivalents$27.9M+43.0%
Total debt$45.0M-43.3%
Total equity$67.6M+21.7%
Total assets$222.9M+7.8%

Cash flow

See full
Operating cash flow-$3.0M-261%
CapEx$233.0K+108%
Free cash flow-$3.3M-243%

Valuation

See full
Market cap$573.06M+124%
Enterprise value$590.17M+86.7%
P/S2.9×-1.0×

Profitability

See full
Gross margin64%
Operating margin-6.2%-2.1pp
Net margin-9.8%-2.8pp
FCF margin3.5%+1.9pp

Returns & leverage

See full
Return on equity-15.5%-5.6pp
Debt / equity0.7×-0.8×
Current ratio1.6×-0.7×

Where this comes from

Reported directly by Cerus in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: Cerus’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cerus's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cerus's investing cash flow?
Cerus (CERS) reported investing cash flow of $9.86M in Q1 2026.
How has Cerus's investing cash flow changed year-over-year?
Cerus's investing cash flow increased by 929.3% year-over-year, from -$1.19M to $9.86M.
What does investing cash flow mean?
Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.